TSXV - Delayed Quote CAD

XORTX Therapeutics Inc. (XRTX.V)

1.2300
-0.0100
(-0.81%)
At close: June 13 at 11:04:32 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
3,993.1590
4,118.3190
6,045.9860
10,290.6060
2,910.6050
Operating Income
-3,993.1590
-4,118.3190
-6,045.9860
-10,290.6060
-2,910.6050
Net Non Operating Interest Income Expense
108.7270
121.9080
253.5430
103.5890
-4.4510
Other Income Expense
2,891.3490
683.0650
3,634.3780
2,468.1350
1,335.7820
Pretax Income
-993.0830
-3,313.3460
-2,158.0650
-7,718.8820
-1,579.2740
Net Income Common Stockholders
-993.0830
-3,313.3460
-2,158.0650
-7,718.8820
-1,579.2740
Diluted NI Available to Com Stockholders
-993.0830
-3,313.3460
-2,158.0650
-7,718.8820
-1,579.2740
Basic EPS
-0.10
-1.15
-1.09
-4.71
-1.20
Diluted EPS
-0.10
-1.15
-1.09
-4.71
-1.20
Basic Average Shares
3,205.4720
2,878.5140
1,981.7340
1,479.9130
1,094.1820
Diluted Average Shares
3,205.4720
2,878.5140
1,981.7340
1,479.9130
1,094.1820
Total Expenses
3,993.1590
4,118.3190
6,045.9860
10,290.6060
2,910.6050
Net Income from Continuing & Discontinued Operation
-993.0830
-3,313.3460
-2,158.0650
-7,718.8820
-1,579.2740
Normalized Income
-3,884.4320
-3,996.4110
-5,792.4430
-10,187.0170
-2,915.0560
Interest Income
--
--
--
101.3668
--
Interest Expense
--
--
--
0
4.3905
Net Interest Income
108.7270
121.9080
253.5430
103.5890
-4.4510
EBIT
-3,993.1590
-4,118.3190
-6,045.9860
-10,290.6060
-2,910.6050
EBITDA
-3,882.0320
-4,001.0450
-5,906.2920
-10,232.4600
-2,896.3390
Reconciled Depreciation
111.1270
117.2740
139.6940
58.1460
14.2660
Net Income from Continuing Operation Net Minority Interest
-993.0830
-3,313.3460
-2,158.0650
-7,718.8820
-1,579.2740
Total Unusual Items Excluding Goodwill
2,891.3490
683.0650
3,634.3780
2,468.1350
1,335.7820
Total Unusual Items
2,891.3490
683.0650
3,634.3780
2,468.1350
1,335.7820
Normalized EBITDA
-6,773.3810
-4,684.1100
-9,540.6700
-12,700.5950
-4,232.1210
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

002898.SZ *ST SAILONG
12.45
+1.97%
 
MEOBF Mesoblast Limited
0.9600
-33.33%
 
DRUG.CN Bright Minds Biosciences Inc.
38.83
0.00%
 
AGN.CN Algernon Pharmaceuticals Inc.
0.0950
0.00%
 
PEG.CO Pharma Equity Group A/S
0.1200
+5.26%
 
MBIO.CN MindBio Therapeutics Corp.
0.0100
0.00%
 
NRX.V NurExone Biologic Inc.
0.6400
-3.03%
 
MSCL.TO Satellos Bioscience Inc.
0.5400
-6.90%
 
IGMS IGM Biosciences, Inc.
1.2100
0.00%
 
CVKD Cadrenal Therapeutics, Inc.
13.86
-7.54%